ToddMZimmermanMD
Oncology • Burr Ridge, ILAssociate Professor of Medicine, University of Chicago Medicine
Dr. Zimmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
180 Harvester Dr Ste 110
Burr Ridge, IL 60527Phone+1 773-834-4064- Is this information wrong?
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1992 - 1995
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1987 - 1992
University of Illinois College of MedicineClass of 1989
Certifications & Licensure
IL State Medical License 1991 - 2020
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma Start of enrollment: 1997 Sep 01
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer Start of enrollment: 1999 Feb 01
- Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Start of enrollment: 1998 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsIndatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a studyKevin R. Kelly, Sikander Ailawadhi, David S. Siegel, Leonard T. Heffner, George Somlo, Sundar Jagannath, Todd M. Zimmerman, Nikhil C. Munshi, Sumit Madan, Asher Chanan...> ;The Lancet. Haematology. 2021 Nov 1
- 69 citationsBortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a random..., , , , , , , , , , , , , , , , > ;The Lancet. Haematology. 2021 Jan 1
- 49 citationsCarfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma., , , , , , , , , , , , , , , , , , , > ;Blood. 2020 Nov 26
- Join now to see all
Hospital Affiliations
OSF Healthcare Little Company of Mary Medical CenterEvergreen Park, Illinois
University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
